Christine Tse

Cooley advised MongoDB (Nasdaq: MDB), a leading database for modern applications, on its acquisition of Voyage AI, a pioneer in state-of-the-art embedding and reranking models that power next-generation artificial intelligence applications.

Cooley advised Inmagene Biopharmaceuticals, a privately held, global clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory diseases, on its definitive merger agreement with Ikena Oncology (Nasdaq: IKNA).

Cooley advised Tvardi Therapeutics, a privately held, clinical-stage biopharmaceutical company focused on the development of novel, oral, small-molecule therapies targeting STAT3 to treat fibrosis-driven diseases, on its definitive merger agreement to combine in an all-stock transaction with Cara Therapeutics (Nasdaq: CARA), a development-stage biopharmaceutical company that has been leading a new treatment paradigm to improve the lives of patients suffering from pruritus.

Cooley advised Jackpocket, the first licensed third-party lottery courier app in the US, on its definitive agreement to be acquired by DraftKings for $750 million.

Cooley advised Liminal BioSciences, a Canada-based development-stage biopharmaceutical companylisted on Nasdaq, on its all-cash cross-border sale to Structured Alpha, a fund managed by Thomvest Asset Management